RxDoctor Payments Data

Luke Marone, MD

Vascular Surgery · Sandy Springs, GANPI 1407820483

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,175 of the $9,410 with a category attached, or 76.2%. 23 manufacturers reported payments, led by Boston Scientific at 28.6% of the total. Reporting peaked in 2019 at $3,484 and has fallen 92.9% since, to $247 in 2024.

$9,410in general payments, 2019–2025

Across 126 payments — averaging $74.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Medtronic$2K
  • Canon Medical Systems USA, Inc.$1K
  • W. L. Gore & Associates, Inc.$1K
  • Endologix LLC$608
  • Cook Medical LLC$409
  • plus $1K from 17 others
$13,227in research payments, 2019–2025

Across 14 payments — averaging $944.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$6K
  • EKOS Corporation$6K
  • Philips North America LLC$1K

What the payments were for

  • Travel & lodging$2,23524%
  • Food & beverage$7,17576%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,410 in reported general payments places this provider in the 65th percentile of 176 vascular surgery providers in Georgia.

See all vascular surgery providers in Georgia

Medicare billing

Part B allowed, 2024
$16,662
Medicare patients
42
Services billed
125

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate17$257

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Sandy Springs

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →